Patentable subject matter, TRIPS and the European Biotechnology Directive: Australia and patenting human genes
- PMID: 16617532
Patentable subject matter, TRIPS and the European Biotechnology Directive: Australia and patenting human genes
Similar articles
-
The gene patenting controversy: a convergence of law, economic interests, and ethics.Brooklyn Law Rev. 2001 Fall;67(1):233-48. Brooklyn Law Rev. 2001. PMID: 12645549 No abstract available.
-
Patents. U.S. Supreme Court delves into what is and isn't patentable.Science. 2009 Jun 12;324(5933):1374. doi: 10.1126/science.324_1374. Science. 2009. PMID: 19520926 No abstract available.
-
Towards harmonization: the European biotechnology patent directive.J Biolaw Bus. 2002;5(3):64-8. J Biolaw Bus. 2002. PMID: 12816122
-
Biotechnology patenting policy in the European Union--as exemplified by the development in Germany.Adv Biochem Eng Biotechnol. 2007;107:13-39. doi: 10.1007/10_2007_049. Adv Biochem Eng Biotechnol. 2007. PMID: 17522818 Review.
-
The attack of the clones: patent law and stem cell research.J Law Med. 2003 May;10(4):488-505. J Law Med. 2003. PMID: 12852321 Review.